Showing results (121-130 of 155) with videos related to

Sort By:
Pageof 16
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 2, 2007
[Present status of home therapy cancer patients using an infusor]Yasushi Tsuji, Takahiro Tsushima, Shingo Tanaka, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|March 23, 2016
Chemotherapy-induced nausea and vomiting is less controlled at delayed phase in patients with esophageal cancer: a prospective registration study by the CINV Study Group of JapanYoshifumi Baba, Hideo Baba, Sachiko Yamamoto, et al.
Japanese Journal of Clinical Oncology|January 22, 2010
Efficacy and feasibility of combination chemotherapy with S-1 and cisplatin (2 weeks regimen) for advanced gastric cancerSeiichiro Abe, Yasushi Tsuji, Takahiro Tsushima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 2, 2003
[A case of irinotecan-resistant colon cancer responding to chronotherapy with oxaliplatin, 5-FU, l-LV]Tamotsu Sagawa, Yasushi Tsuji, Norihiro Takayanagi, et al.
Japanese Journal of Clinical Oncology|August 31, 2004
Phase II study of sequential methotrexate and 5-fluorouracil chemotherapy against peritoneally disseminated gastric cancer with malignant ascites: a report from the Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group, JCOG 9603 TrialTakekazu Yamao, Yasuhiro Shimada, Kuniaki Shirao, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 18, 2007
[Two cases of advanced gastric cancer in which paclitaxel proved effective after resistance to docetaxel]Takahiro Tsushima, Yasushi Tsuji, Seiichiro Abe, et al.
Molecular Cancer Research : MCR|July 13, 2017
EGFR Downregulation after Anti-EGFR Therapy Predicts the Antitumor Effect in Colorectal CancerYasuyuki Okada, Tetsuo Kimura, Tadahiko Nakagawa, et al.
Cancer Medicine|June 16, 2023
Genomic characterization between HER2-positive and negative gastric cancer patients in a prospective trialQingjiang Hu, Eiji Oki, Teppei Yamada, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 11, 2003
[A case responding to weekly paclitaxel (TXL) therapy as third line chemotherapy for scirrhous type gastric cancer]Tamotsu Sagawa, Yasushi Tsuji, Norihiro Takayanagi, et al.
Oncology|May 5, 2012
Clinical benefit of high-sensitivity KRAS mutation testing in metastatic colorectal cancer treated with anti-EGFR antibody therapyTetsuo Kimura, Koichi Okamoto, Hiroshi Miyamoto, et al.
Pageof 16